Oncobiologics is a complex biosimilar company focused on developing technically challenging biosimilars in a cost effective way. The first wave of Phase 3 ready products include ONS-3010 (Humira® Biosimilar) and ONS-1045 (Avastin® Biosimilar).
oncobiologics.com
Employees: 51-200
Total raised: $81M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | Perceptive... | perceptive... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 23.12.2015 | - | $50M | - |
| 27.07.2015 | - | $31M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 23.12.2015 | Oncobiologics raising $50M for Avastin, Humira biosimilars | Oncobiologics has six more biosimilars in preclinical study, the company says. Promoted Telemedici... | medcitynew... |
| 29.09.2015 | Oncobiologics Raises Equity Funding | Oncobiologics, Inc., a Cranbury, New Jersey-based clinical-stage biopharmaceutical company, closed a... | finsmes.co... |
| 28.07.2015 | Oncobiologics Receives $31M | CRANBURY, NJ, Oncobiologics, announced the closing of a $31 million financing. >> Click her... | vcnewsdail... |
| 27.07.2015 | Daily funding roundup - July 27, 2015 | Palantir received $450M; DraftKings added $300M; Secret Escapes bagged $60M Buyatab Online Inc., a ... | vator.tv/n... |
| 27.07.2015 | Oncobiologics raises $31M to develop biosimilars as Humira, ... | Humira is the first drug for which Oncobiologics is developing a biosimilar; it’s entering phase 3 t... | medcitynew... |
| 27.07.2015 | Oncobiologics Closes $31M Financing | Oncobiologics, Inc., a Cranbury, NJ-based biopharmaceutical company focused on developing and commer... | finsmes.co... |
| 26.07.2015 | Oncobiologics raises $31M for a PhIII biosimilar play agains... | Oncobiologics CEO Pankaj Mohan Four years ago, Pankaj Mohan set out to build an independent biosimi... | fiercebiot... |
| 14.10.2011 | NJ biotherapeutics co licensing and research deals worth $80... | At its official opening, Oncobiologics also announced a strategic partnership with Fox Chase Cancer ... | medcitynew... |
| - | Oncobiologics raises $31M to develop biosimilars as Humira, ... | Oncobiologics, a New Jersey maker of monoclonal antibody biosimilars for top-sellers like Humira, ju... | medcitynew... |
Show more